Related Experiment Video
Updated: Dec 6, 2025

Author Spotlight: Streamlining Rice Breeding with CRISPR/Cas for Obtaining Optimal Phenotypic and Agronomic Traits
Published on: January 3, 2025
Advances in the Xoo-rice pathosystem interaction and its exploitation in disease management
Johnson Beslin Joshi1, Loganathan Arul, Jegadeesan Ramalingam
1Department of Plant Biotechnology, Centre for Plant Molecular Biology and Biotechnology, Tamil Nadu Agricultural University, Coimbatore 641 003, India.
Abstract:
Bacterial blight caused by Xanthomonas oryzae pv. oryzae (Xoo), is one of the devastating diseases of rice worldwide. The pathogen reported to cause 70% crop loss in some of the susceptible genotypes under disease favoring environments, viz., temperature ranging between 25 to 34°C and relative humidity more than 70%. In Xoo, about 245 genes govern the pathogenicity and host specificity. The hypersensitive response and pathogenicity (hrp) genes responsible for disease occurrence were clustered in the pathogenicity island of 31.3 Kb. The protein secreted through type three secretory system and type one secretory system mediates infection and establishment of the pathogen inside the host. However, elicitor molecules from Xoo triggered the resistant response in rice against the pathogen. An array of resistant genes (R genes) was known to be invoked by the host to combat the bacterial infection. To date, of the 45 Xa genes in rice, nine were cloned and characterized. The evolution of new races has made the task of developing resistant rice genotypes more challenging as it demands a comprehensive breeding strategy involving the best use of R genes from the existing gene pool. Thus, to combat the infection from the existing races and to slow down the emergence of new Xoo races, pyramiding two or more R genes was found to be effective against bacterial blight disease. In India, the successfully commercialized example includes the development of rice genotypes, viz., Improved Pusa Basmati- 1, Improved Samba Mahsuri, PR106, Type 3 Basmati, and Mahsuri with selected R genes, viz., xa5, Xa4, xa13 and Xa21 against bacterial blight resistance. This review primarily portray Xoo-rice interactions and provides opportunities for its effective management through sustainable technologies.
More Related Videos
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
15:30A Telemetric, Gravimetric Platform for Real-Time Physiological Phenotyping of Plant–Environment Interactions
Published on: August 5, 2020
Related Concept Videos
Taste Buds and Receptors
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...